| Identification | Back Directory | [Name]
Peliglitazar (racemate) | [CAS]
331744-72-0 | [Synonyms]
BMS 426707-01 racemate
Peliglitazar (racemate)
Glycine, N-[(4-methoxyphenoxy)carbonyl]-N-[1-[4-[2-(5-methyl-2-phenyl-4-oxazolyl)ethoxy]phenyl]ethyl]- | [Molecular Formula]
C30H30N2O7 | [MOL File]
331744-72-0.mol | [Molecular Weight]
530.57 |
| Hazard Information | Back Directory | [Description]
Peliglitazar racemate is the racemate of Peliglitazar. Peliglitazar is a novel dual α/γ PPAR activator. Peliglitazar, is a novel dual α/γperoxisome proliferator-activated receptor (PPAR) activator. It has been shown that Peliglitazar has both glucose and lipid-lowering effects when tested in animal models of diabetes and dyslipidemia[1]. | [Uses]
Peliglitazar racemate is the racemate of Peliglitazar. Peliglitazar is a novel dual α/γ PPAR activator. | [in vivo]
Peliglitazar, is a novel dual α/γperoxisome proliferator-activated receptor (PPAR) activator. It has been shown that Peliglitazar has both glucose and lipid-lowering effects when tested in animal models of diabetes and dyslipidemia[1]. | [storage]
Store at -20°C | [References]
[1]. Wang L, et al. Metabolism and disposition of 14C-labeled peliglitazar in humans. Drug Metab Dispos. 2011 Feb;39(2):228-38. |
|
|